Martin Henriksson

3.2k total citations · 1 hit paper
79 papers, 2.2k citations indexed

About

Martin Henriksson is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Martin Henriksson has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Economics and Econometrics, 22 papers in Cardiology and Cardiovascular Medicine and 15 papers in Surgery. Recurrent topics in Martin Henriksson's work include Health Systems, Economic Evaluations, Quality of Life (34 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Acute Myocardial Infarction Research (7 papers). Martin Henriksson is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (34 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Acute Myocardial Infarction Research (7 papers). Martin Henriksson collaborates with scholars based in Sweden, United Kingdom and United States. Martin Henriksson's co-authors include Magnus Janzon, Pål Hasvold, Tomas Jernberg, Marcus Thuresson, Hans Hjelm, Kristina Burström, Ulf‐G. Gerdtham, Lars‐Åke Levin, Per Carlsson and Sun Sun and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Martin Henriksson

74 papers receiving 2.2k citations

Hit Papers

Cardiovascular risk in post-myocardial infarction patient... 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Henriksson Sweden 23 795 595 545 296 226 79 2.2k
Matthew D. Solomon United States 28 889 1.1× 500 0.8× 255 0.5× 189 0.6× 265 1.2× 98 2.2k
Dana C. Miskulin United States 38 640 0.8× 608 1.0× 416 0.8× 234 0.8× 269 1.2× 93 4.4k
Cornelis Boersma Netherlands 17 589 0.7× 416 0.7× 492 0.9× 100 0.3× 246 1.1× 78 2.5k
Stephen S. Johnston United States 28 989 1.2× 748 1.3× 261 0.5× 155 0.5× 329 1.5× 135 3.2k
Candace Gunnarsson United States 28 641 0.8× 1.0k 1.7× 235 0.4× 181 0.6× 359 1.6× 112 2.8k
Craig Fleming United States 18 615 0.8× 527 0.9× 530 1.0× 405 1.4× 248 1.1× 40 2.6k
Mary E. Charlson United States 16 328 0.4× 480 0.8× 200 0.4× 221 0.7× 177 0.8× 29 1.5k
Natasha Burke Canada 20 586 0.7× 419 0.7× 214 0.4× 135 0.5× 172 0.8× 47 1.9k
Roberta Ara United Kingdom 27 245 0.3× 647 1.1× 1.2k 2.3× 455 1.5× 221 1.0× 63 2.7k
Jacques LeLorier Canada 13 323 0.4× 434 0.7× 526 1.0× 169 0.6× 169 0.7× 24 1.8k

Countries citing papers authored by Martin Henriksson

Since Specialization
Citations

This map shows the geographic impact of Martin Henriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Henriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Henriksson more than expected).

Fields of papers citing papers by Martin Henriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Henriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Henriksson. The network helps show where Martin Henriksson may publish in the future.

Co-authorship network of co-authors of Martin Henriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Henriksson. A scholar is included among the top collaborators of Martin Henriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Henriksson. Martin Henriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasselgren, Kristina, Martin Henriksson, Bård I. Røsok, et al.. (2024). Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial. SHILAP Revista de lepidopterología. 5(1). e367–e367. 2 indexed citations
2.
Pettersson, Maria, Anna Hammarsjö, Ann Nordgren, et al.. (2023). The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Scientific Reports. 13(1). 6904–6904. 17 indexed citations
3.
Kechagias, Stergios, et al.. (2023). Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease. Hepatology Communications. 7(7). 16 indexed citations
4.
Nasr, Patrik, Mikael Forsgren, Nils Dahlström, et al.. (2023). A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol. BMC Gastroenterology. 23(1). 454–454. 3 indexed citations
5.
Sørensen, L., et al.. (2022). Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism. The Journal of Pediatrics. 256. 38–43.e3. 7 indexed citations
6.
Teni, Fitsum Sebsibe, Ulf‐G. Gerdtham, Reiner Leidl, et al.. (2021). Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population. Quality of Life Research. 31(3). 697–712. 39 indexed citations
7.
Hasselgren, Kristina, Martin Henriksson, Bård I. Røsok, et al.. (2021). Health Economic Evaluation of Patients with Colorectal Liver Metastases Randomized to ALPPS or TSH - Analysis from the LIGRO Trial. HPB. 23. S99–S99. 1 indexed citations
8.
Burström, Kristina, Fitsum Sebsibe Teni, Ulf‐G. Gerdtham, et al.. (2020). Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. PharmacoEconomics. 38(8). 839–856. 47 indexed citations
9.
Henriksson, Martin, et al.. (2017). How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden. Health and Quality of Life Outcomes. 15(1). 151–151. 15 indexed citations
10.
Henriksson, Martin, et al.. (2016). A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus. PharmacoEconomics. 34(6). 569–585. 29 indexed citations
11.
Henriksson, Martin, et al.. (2015). Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics. British Journal of Dermatology. 174(3). 579–587. 23 indexed citations
12.
Henriksson, Martin, et al.. (2015). A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus. Value in Health. 18(7). A607–A607. 13 indexed citations
13.
Bodegård, Johan, Johan Sundström, Carl Johan Östgren, et al.. (2015). Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting. Primary care diabetes. 9(5). 330–337. 19 indexed citations
14.
Henriksson, Martin, et al.. (2015). Applying Symptom-Based Utility Functions in Health Economic Modelling: A Case Study of Uterine Fibroids. Value in Health. 18(7). A728–A728. 1 indexed citations
15.
Henriksson, Martin, et al.. (2015). The Relationship Between Disease Severity and Quality of Life In Patients With Moderate to Severe Psoriasis. Value in Health. 18(7). A675–A675. 1 indexed citations
16.
Bodegård, Johan, Johan Sundström, Bodil Svennblad, et al.. (2014). Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden. Value in Health. 17(7). A338–A338. 1 indexed citations
17.
Hemingway, Harry, Martin Henriksson, Ruoling Chen, et al.. (2010). The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health Technology Assessment. 14(9). 1–151, iii. 38 indexed citations
18.
Janzon, Magnus, Martin Henriksson, Ole Hauch, et al.. (2010). Abstract 17295: Health Economics in the PLATelet inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns. Circulation. 122. 4 indexed citations
19.
Speight, P. M., Stephen Palmer, David R. Moles, et al.. (2006). The cost-effectiveness of screening for oral cancer in primary care. Health Technology Assessment. 10(14). 1–144, iii. 160 indexed citations
20.
Henriksson, Martin, Fredrik Lundgren, & Per Carlsson. (2006). Informing the efficient use of health care and health care research resources ‐ the case of screening for abdominal aortic aneurysm in Sweden. Health Economics. 15(12). 1311–1322. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026